Additionally, PER1 overexpression in endometrial cancer cells promotes the expression of immune factors TNF-α and IL-6, while upregulating immune checkpoints programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1). Here, IL6 is linked to endometrial cancer.